Skip to content

Clinical trials

Phase 2 Diabetes Mellitus trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Phase 2 Country / region: Netherlands Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20071
20091
20111
20131
20151
20161
20172
20181
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Novo Nordisk A/S2
Akros Pharma Inc.1
Assistance Publique - Hôpitaux de Paris1
Biogen1
Diamyd Medical AB1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Pharming Technologies B.V.1
Radboud University Medical Center1
Solvay Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus14
Diabetes Mellitus, Type 25
Diabetes Mellitus, Type 12
Endocrine System Diseases2
Hypertension2
Insulin Resistance2
Metabolic Syndrome2
Atherosclerosis1
Autoimmune Diseases1
Body Weight1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.